Genetic risk factors for alcoholic cirrhosis - genome-wide case-control study
Genetic risk factors for alcoholic cirrhosis - genome-wide case-control study
批准号:
8334639
负责人:
Christopher Paul Day
金额:
$55.22万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-20 至 2016-08-31
关键词:
AccountingAffectAgeAge related macular degenerationAlcohol abuseAlcohol consumptionAlcoholic Liver CirrhosisAlcoholic Liver DiseasesAlcoholic beverage heavy drinkerAlcoholismAlcoholsAldehydesAlgorithmsAllelesAnimal ModelApplications GrantsArchitectureAustraliaBiliaryBiologicalCandidate Disease GeneCase-Control StudiesChildCirrhosisClinicalClinical DataCodeCollectionComplexConsumptionCountryDNADNA LibraryDataData AnalysesData CollectionDatabasesDeath RateDevelopmentDiagnosisDiseaseDizygotic TwinsDrug Delivery SystemsEnsureEthnic OriginExclusion CriteriaFatty LiverFatty acid glycerol estersFibrosisFloxacillinFranceFunctional disorderGenderGene ExpressionGenesGeneticGenetic PolymorphismGenetic RiskGenomicsGenotypeGermanyHLA-B AntigensHandHeavy DrinkingHepaticHepatitis CHeritabilityIndianaIndividualInflammationInflammatoryInjuryInternationalLDL Cholesterol LipoproteinsLeadLifeLinkLinkage DisequilibriumLiverLiver CirrhosisLiver diseasesLocationMetabolismMicroarray AnalysisMinorityModalityMorbidity - disease rateNucleotidesOrganOutcomeOxidative StressPathogenesisPathway interactionsPatientsPatternPharmaceutical PreparationsPhenotypePlasmaPredispositionPreparationPrevalencePrincipal InvestigatorProcessProtocols documentationRNARaceRecommendationReportingResearchResearch PersonnelRiskRisk FactorsSamplingSchizophreniaSeriesSeverity of illnessShippingShipsSiteSpecimenStagingSusceptibility GeneSwitzerlandTechniquesTestingTherapeuticTimeTwin StudiesVariantVeteransWomanbasebiobankcase controlchronic liver diseasecohortcost effectivedesigndisorder controldisorder riskexomeexperiencegenetic risk factorgenome sequencinggenome-widehuman diseaseimprovedinnovationinsightlight microscopyliver biopsymeetingsmembermenmortalitymultidisciplinarynon-alcoholic fatty livernovelnovel diagnosticspreventprimary sclerosing cholangitisproblem drinkerprogramsprospectiverepositorysample collectionsuccesstherapeutic targettooltraitworking group
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Alcoholic liver cirrhosis (ALC) remains a major cause of morbidity and mortality and is the most common cause of liver disease In the developed world. It is unknown why only a minority of heavy and prolonged alcohol mis-users develop ALC. There is a weak relationship between the amount of alcohol consumed and development of ALC such that some develop severe liver disease with moderate levels of alcohol use although others with very high levels of consumption only progress to mild liver Injury. Apart from a greater vulnerability in women than men, few contributory factors have been identified for the development of ALC. To date, only one genetic polymorphism (in PNPLA3) has shown replicable positive result as a risk factor for ALC, although evidence from twin studies and Inter-ethnic variability in ALC mortality rates, supports a genetic component in ALC. Candidate gene studies have been inconclusive but these have generally been too small to yield definitive re-sults. Risk identification is likely to provide Insights into the pathogenic process and may suggest strategies for hami reduction. High-throughput genome-wide search for genetic changes called single nucleotide polymor-phlsms (SNPs) provides an ideal opportunity to Identify genes responsible for this polygenic disorder and is now technically feasible. We have gathered an experienced multidisciplinary team from the USA, Australia, France, Germany, Switzerland and UK with a proven track record in clinical alcoholic liver disease and in genetics. We propose to prospectively collect clinical data and DNA from 1250 heavy drinkers without known liver disease (Controls) and 1250 heavy drinkers with ALC (Cases). To these 2500 specimens we will add clinical data/DNAfrom more than 2700 heavy drinkers (~1100 with ALC) from existing databases/biorepositories in the possession of several study co-PIs. Cases and controls will be matched for age, gender, race/ethnicity and country of origin. DNA will be genotyped with the lllumina Human660-Quad SNP an-ay at CIDR to generate SNP profiles in the Cases and Controls. Data will be analysed to identify genetic variants that predispose some heavy drinkers to ALC in order to answer the question 'Why do only a minority of alcoholics develop liver cirrhosis?"
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic risk factors for alcoholic cirrhosis - genome-wide case-control study
-
批准号:8525258
-
项目类别:
-
资助金额:$51.84万
-
财政年份:2011
-
负责人:Christopher Paul Day
-
依托单位:
Genetic risk factors for alcoholic cirrhosis - genome-wide case-control study
-
批准号:8718935
-
项目类别:
-
资助金额:$51.86万
-
财政年份:2011
-
负责人:Christopher Paul Day
-
依托单位:
Genetic risk factors for alcoholic cirrhosis - genome-wide case-control study
-
批准号:8041424
-
项目类别:
-
资助金额:$55.87万
-
财政年份:2011
-
负责人:Christopher Paul Day
-
依托单位:
海外基金